Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Episodic disability framework in the context of Long COVID: Findings from a community-engaged international qualitative study.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: San Francisco, CA : Public Library of Science
    • الموضوع:
    • نبذة مختصرة :
      Competing Interests: The authors have declared that no competing interests exist.
      Background: Increasing numbers of adults are living with the health-related consequences of Long COVID. The Episodic Disability Framework (EDF), derived from perspectives of adults living with HIV, characterizes the multi-dimensional and episodic nature of health-related challenges (disability) experienced by an individual. Our aim was to determine the applicability of the Episodic Disability Framework to conceptualize the health-related challenges experienced among adults living with Long COVID.
      Methods: We conducted a community-engaged qualitative descriptive study involving online semi-structured interviews. We recruited adults who self-identified as living with Long COVID via collaborator community organizations in Canada, Ireland, United Kingdom, and United States. We purposively recruited for diversity in age, gender identity, ethnicity, sexual orientation, and time since initial COVID-19 infection. We used a semi-structured interview guide informed by the EDF to explore experiences of disability living with Long COVID, specifically health-related challenges and how challenges were experienced over time. We conducted a group-based content analysis.
      Results: Of the 40 participants, the median age was 39 years; and the majority were white (73%), women (63%), living with Long COVID for ≥ 1 year (83%). Consistent with the Episodic Disability Framework, disability was described as multi-dimensional and episodic, characterized by unpredictable periods of health and illness. Experiences of disability were consistent with the three main components of the Framework: A) dimensions of disability (physical, cognitive, mental-emotional health challenges, difficulties with day-to-day activities, challenges to social inclusion, uncertainty); B) contextual factors, extrinsic (social support; accessibility of environment and health services; stigma and epistemic injustice) and intrinsic (living strategies; personal attributes) that exacerbate or alleviate dimensions of disability; and C) triggers that initiate episodes of disability.
      Conclusions: The Episodic Disability Framework provides a way to conceptualize the multi-dimensional and episodic nature of disability experienced by adults living with Long COVID. The Framework provides guidance for future measurement of disability, and health and rehabilitation approaches to enhance practice, research, and policy in Long COVID.
      (Copyright: © 2025 O’Brien et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
    • References:
      JAMA Health Forum. 2022 May 6;3(5):e221809. (PMID: 36219031)
      Qual Health Res. 2005 Nov;15(9):1277-88. (PMID: 16204405)
      J Occup Rehabil. 2024 Jun;34(2):335-349. (PMID: 38388910)
      Lancet Infect Dis. 2022 Apr;22(4):e102-e107. (PMID: 34951953)
      Patient. 2022 Sep;15(5):565-576. (PMID: 35478078)
      Disabil Rehabil. 2024 Jul 24;:1-10. (PMID: 39049529)
      Nat Med. 2021 Apr;27(4):601-615. (PMID: 33753937)
      BMJ. 2023 Mar 6;380:535. (PMID: 36878599)
      Health Expect. 2024 Apr;27(2):e14037. (PMID: 38634418)
      BMJ. 2022 Aug 1;378:e069868. (PMID: 35914783)
      EClinicalMedicine. 2021 Aug;38:101019. (PMID: 34308300)
      BMJ Open. 2022 Mar 7;12(3):e060826. (PMID: 35256450)
      BMJ Glob Health. 2021 Sep;6(9):. (PMID: 34551971)
      Soc Sci Med. 2021 Jan;268:113426. (PMID: 33199035)
      PLoS One. 2021 Jan 13;16(1):e0245556. (PMID: 33439908)
      MMWR Morb Mortal Wkly Rep. 2024 Feb 15;73(6):135-136. (PMID: 38359012)
      Pain Rep. 2021 Apr 13;6(1):e913. (PMID: 33987484)
      medRxiv. 2022 May 27;:. (PMID: 35664995)
      BMJ. 2020 Apr 20;369:m1546. (PMID: 32312767)
      Disabil Rehabil. 2021 Jan;43(2):229-240. (PMID: 31161816)
      J Gen Intern Med. 2023 Apr;38(5):1127-1136. (PMID: 36795327)
      BJGP Open. 2020 Dec 15;4(5):. (PMID: 33051223)
      Nat Med. 2024 Aug;30(8):2148-2164. (PMID: 39122965)
      Clin Microbiol Infect. 2022 Apr;28(4):611.e9-611.e16. (PMID: 34763058)
      BMC Health Serv Res. 2023 Dec 12;23(1):1396. (PMID: 38087299)
      Health Qual Life Outcomes. 2008 Oct 04;6:76. (PMID: 18834538)
      SSM Qual Res Health. 2022 Dec;2:100167. (PMID: 36092770)
      JAMA. 2023 Jun 13;329(22):1934-1946. (PMID: 37278994)
      Front Public Health. 2022 Nov 04;10:970378. (PMID: 36407988)
      J Cent Nerv Syst Dis. 2023 Aug 19;15:11795735231195759. (PMID: 38025402)
      AIDS Care. 2014 Feb;26(2):240-5. (PMID: 23799874)
      Nat Rev Immunol. 2023 Oct;23(10):618-634. (PMID: 37433988)
      Lancet. 2023 Mar 11;401(10379):795. (PMID: 36906338)
      CMAJ Open. 2023 Jun 13;11(3):E504-E515. (PMID: 37311595)
      Brain Behav Immun. 2022 Mar;101:93-135. (PMID: 34973396)
      Medicina (Kaunas). 2021 Apr 26;57(5):. (PMID: 33925784)
      J Med Ethics. 2017 Aug;43(8):549-557. (PMID: 27920164)
      Med Health Care Philos. 2014 Nov;17(4):529-40. (PMID: 24740808)
      Health Expect. 2022 Aug;25(4):1753-1765. (PMID: 35557480)
      BMJ Open. 2022 Jan 11;12(1):e050979. (PMID: 35017239)
      Nat Commun. 2022 Jun 28;13(1):3528. (PMID: 35764621)
      J Infect Dis. 2022 Nov 1;226(9):1593-1607. (PMID: 35429399)
      Chronic Illn. 2016 Dec;12(4):292-307. (PMID: 27127189)
      BMJ. 2021 Mar 25;372:n829. (PMID: 33766927)
      PLoS One. 2022 Mar 8;17(3):e0264331. (PMID: 35259179)
      Lancet. 2022 Jan 22;399(10322):355. (PMID: 35065779)
      Disabil Rehabil. 2014;36(4):319-29. (PMID: 23688295)
      BMJ Glob Health. 2023 Mar;8(3):. (PMID: 36863719)
      Nat Commun. 2024 Jan 4;15(1):17. (PMID: 38177128)
      J Int AIDS Soc. 2009 Nov 09;12:5. (PMID: 19900284)
      BMJ. 2022 Sep 21;378:o2188. (PMID: 36130797)
      Physiother Can. 2024 Mar 06;76(1):8-24. (PMID: 38465303)
      Soc Sci Med. 2023 Dec;338:116336. (PMID: 37918226)
      Phys Ther. 2020 Oct 30;100(11):1906-1909. (PMID: 32737967)
      Front Neurol. 2020 Sep 18;11:1025. (PMID: 33071931)
      EClinicalMedicine. 2022 Dec 01;55:101762. (PMID: 36474804)
      J Med Virol. 2022 Apr;94(4):1419-1427. (PMID: 34783052)
      Eur J Public Health. 2024 Jun 7;34(3):489-496. (PMID: 38423541)
      SSM Qual Res Health. 2022 Dec;2:100177. (PMID: 36212783)
      BMC Public Health. 2019 Jun 28;19(1):840. (PMID: 31253111)
      Nat Rev Microbiol. 2023 Mar;21(3):133-146. (PMID: 36639608)
      BMJ Open. 2023 Mar 22;13(3):e067166. (PMID: 36948566)
      PLoS One. 2023 Feb 16;18(2):e0281884. (PMID: 36795701)
    • الموضوع:
      Date Created: 20250227 Date Completed: 20250510 Latest Revision: 20250510
    • الموضوع:
      20250510
    • الرقم المعرف:
      PMC11867324
    • الرقم المعرف:
      10.1371/journal.pone.0305187
    • الرقم المعرف:
      40014600